NCT04760431 2021-06-02TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN)Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2 Unknown120 enrolled